By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

If you're too busy to keep monitoring your stock portfolio every other day, then investing in stocks that won't cause you a ...

Zepbound (tirzepatide), manufactured by Fortune 500 firm Eli Lilly & Co., bested competitor Wegovy (semaglutide), a product ...

Eli Lilly (LLY) emerges among the top performers in Big Pharma in 2024 with obesity drug success, while Novo Nordisk (NVO) ...

The fight against obstructive sleep apnea (OSA) has taken a monumental leap forward. For the first time, the U.S. Food and ...

During FDA-declared shortages, pharmacists can legally make compounded versions of brand-name medications. But drugmakers and ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 500.39% and ...

Alzheimer's, addiction, cardiovascular diseases, kidney disorders, sleep apnoea, diabetes, obesity, and overweight.

Furthermore, just this week the FDA removed tirzepatide -- the main ingredient in Mounjaro and Zepbound -- from its shortage ...

This proposed rule signals an important shift in the federal approach to obesity management, aligning with the medical ...

The danger and hardship gets worse by the day for civilians in eastern Ukraine. Still, they resist leaving the places that have become their homes. By Tyler Hicks and Gaëlle Girbes Human rights ...

Director-General of the World Health Organization, Tedros Adhanom Ghebreyesus, says he was close to the departure lounge when it was hit. Ukraine's air force says it detected 184 missiles and ...